These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3117701

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
    Bauernfeind A, Bertele RM, Harms K, Hörl G, Jungwirth R, Petermüller C, Przyklenk B, Weisslein-Pfister C.
    Infection; 1987; 15(4):270-7. PubMed ID: 3117700
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J, Ghequire MG, Craggs M, De Mot R, Cornelis P.
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [Abstract] [Full Text] [Related]

  • 5. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
    Wong K, Roberts MC, Owens L, Fife M, Smith AL.
    J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
    [Abstract] [Full Text] [Related]

  • 6. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M, Thomas J, Diggle SP.
    mBio; 2021 May 04; 12(3):. PubMed ID: 33947755
    [Abstract] [Full Text] [Related]

  • 7. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A, Renders NH, Smith S, Overbeek SE, Verbrugh HA.
    FEMS Immunol Med Microbiol; 2000 Jan 04; 27(1):51-7. PubMed ID: 10617790
    [Abstract] [Full Text] [Related]

  • 8. Incidence and risk of cross-colonization in cystic fibrosis holiday camps.
    Hoogkamp-Korstanje JA, van der Laag J.
    Antonie Van Leeuwenhoek; 1980 Jan 04; 46(1):100-1. PubMed ID: 6772098
    [No Abstract] [Full Text] [Related]

  • 9. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A, Whitby JL, Wildy P.
    J Med Microbiol; 1975 Nov 04; 8(4):531-41. PubMed ID: 812999
    [Abstract] [Full Text] [Related]

  • 10. Activity of pyocin S2 against Pseudomonas aeruginosa biofilms.
    Smith K, Martin L, Rinaldi A, Rajendran R, Ramage G, Walker D.
    Antimicrob Agents Chemother; 2012 Mar 04; 56(3):1599-601. PubMed ID: 22183174
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.
    Möller LV, van Alphen L, Grasselier H, Dankert J.
    J Clin Microbiol; 1993 Jul 04; 31(7):1952-4. PubMed ID: 7688756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981.
    Corey M, Allison L, Prober C, Levison H.
    J Infect Dis; 1984 Feb 04; 149(2):283. PubMed ID: 6421945
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.